Kristyn Wunder
Gerontology · Lafayette, LANPI 1841700556
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Insulet Corporation at 37.2% of the total. 2025 is the largest year on record at $189, 3.0 times the $63 reported in 2022. That places this record below the midpoint for gerontology clinicians in LA, where the typical reported total is $485.
Across 19 payments — averaging $25.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insulet Corporation$180
- Dexcom, Inc.$137
- Xeris Pharmaceuticals, Inc.$40
- Tandem Diabetes Care, Inc.$32
- Medtronic$28
- Noven Therapeutics, LLC$20
- plus $47 from 3 others
What the payments were for
- Food & beverage$485100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insulet Corporation | 6 | $180 |
| Dexcom, Inc. | 4 | $137 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| Tandem Diabetes Care, Inc. | 2 | $32 |
| Medtronic | 1 | $28 |
| Noven Therapeutics, LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| Boehringer Ingelheim | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
How this compares
$485 in reported general payments places this provider in the 50th percentile of 64 gerontology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 112 | $111,196 |
| JardianceEmpagliflozin | 61 | $62,493 |
| TrulicityDulaglutide | 41 | $49,249 |
| TradjentaLinagliptin | 19 | $16,154 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 14 | $12,363 |
| RybelsusSemaglutide | 12 | $10,964 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $3,623 |
| Aspirin-Dipyridamole ErAspirin/Dipyridamole | 11 | $3,124 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 35 | $2,844 |
| Humalog Kwikpen U-100Insulin Lispro | 14 | $2,631 |
| Trazodone Hcl | 42 | $1,859 |
| Gabapentin | 143 | $1,706 |
| Atorvastatin Calcium | 132 | $1,115 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 35 | $1,012 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $1,005 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $16 | $78,64880 claims |
| Lilly USA, LLCTrulicity, Insulin Lispro | $17 | $49,89852 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 64 gerontology providers in Louisiana.
Other gerontology in Lafayette
- Brandt SandersLafayette$3K
- Kay MelanconLafayette$3K
- Icela WilliamsLafayette$2K
- Bobbi DerasLafayette$878
- Christopher DuhonLafayette$317
- Christopher VincentLafayette$50
- Jodie HarrisonSlidell$12K
- Whitney StevensSlidell$10K
- Rebekah HendryBossier City$6K
- Jessica GaubertBaton Rouge$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.